Page 347 - Read Online

Liu et al. Novel predictive and prognostic strategies of HBV-related HCC

4. E-Serag HB. Epidemiology of viral hepatitis and hepatocellular S, Burkhardt B, Butler AP, Caldas C, Davies HR, Desmedt C, Eils
carcinoma. Gastroenterology 2012;142:1264-73. R, Eyfjord JE, Foekens JA, Greaves M, Hosoda F, Hutter B, Ilicic T,
5. Huang YT, Jen CL, Yang HI, Lee MH, Su J, Lu SN, Iloeje UH, Chen Imbeaud S, Imielinski M, Jager N, Jones DT, Jones D, Knappskog S,
CJ. Lifetime risk and sex difference of hepatocellular carcinoma Kool M, Lakhani SR, Lopez-Otin C, Martin S, Munshi N C, Nakamura
among patients with chronic hepatitis B and C. J Clin Oncol H, Northcott PA, Pajic M, Papaemmanuil E, Paradiso A, Pearson J
2011;29:3643-50. V, Puente XS, Raine K, Ramakrishna M, Richardson AL, Richter
6. Sharma S, Carballo M, Feld JJ, Janssen HL. Immigration and viral J, Rosenstiel P, Schlesner M, Schumacher TN, Span PN, Teague
hepatitis. J Hepatol 2015;63:515-22. JW, Totoki Y, Tutt AN, Valdes-Mas R, van Buuren MM, Laura
7. Du Y, Su T, Ding Y, Cao G. Effects of antiviral therapy on the van ‘t Veer, Vincent-Salomon A, Waddell N, Yates LR, Australian
recurrence of hepatocellular carcinoma after curative resection or liver Pancreatic Cancer Genome I, Consortium I B C, Consortium I M-S,
transplantation. Hepat Mon 2012;12:e6031. PedBrain I, Zucman-Rossi J, Futreal PA, McDermott U, Lichter P,
8. Hyder O, Marques H, Pulitano C, Marsh JW, Alexandrescu S, Bauer Meyerson M, Grimmond SM, Siebert R, Campo E, Shibata T, Pfister
TW, Gamblin TC, Sotiropoulos GC, Paul A, Barroso E, Clary BM, S M, Campbell PJ, Stratton MR. Signatures of mutational processes in
Aldrighetti L, Ferrone CR, Zhu AX, Popescu I, Gigot JF, Mentha human cancer. Nature 2013;500:415-21.
G, Feng S, Pawlik TM. A nomogram to predict long-term survival 20. Stratton MR, Campbell PJ, Futreal PA. The cancer genome. Nature
after resection for intrahepatic cholangiocarcinoma: an Eastern and 2009;458:719-24.
Western experience. JAMA Surg 2014;149:432-8. 21. Chan HL, Tse C H, Mo F, Koh J, Wong VW, Wong GL, Chan SL,
9. Liu WB, Wu JF, DuY, Cao GW. Cancer Evolution-Development: Yeo W, Sung JJ, Mok TS. High viral load and hepatitis B virus
experience of hepatitis B virus-induced hepatocarcinogenesis. Curr subgenotype ce are associated with increased risk of hepatocellular
Oncol 2016;23:e49-56. carcinoma. J Clin Oncol 2008;26:177-82.
10. Li ZX, Xie ZY, Ni HX, Zhang Q, Lu W, Yin JH, Liu WB, Ding YB, 22. Yang HI, Yuen MF, Chan HL, Han KH, Chen PJ, Kim DY, Ahn SH,
Zhao Y, Zhu YB, Pu R, Zhang HW, Dong HJ, Fu YF, Sun Q, Xu GZ, Chen CJ, Wong VW, Seto WK. Risk estimation for hepatocellular
Cao GW. Mother-to-child transmission of hepatitis B virus: evolution carcinoma in chronic hepatitis B (REACH-B): development and
of hepatocellular carcinoma-related viral mutations in the post- validation of a predictive score. Lancet Oncol 2011;12:568-74.
immunization era. J Clin Virol 2014;61:47-54. 23. Lee MH, Yang HI, Liu J, Batrla-Utermann R, Jen CL, Iloeje UH,
11. Liu S, Zhang H, Gu C, Yin J, He Y, Xie J, Cao G. Associations Lu SN, You S L, Wang LY, Chen CJ. Prediction models of long-
between hepatitis B virus mutations and the risk of hepatocellular term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis
carcinoma: a meta-analysis. J Natl Cancer Inst 2009;101:1066-82. B patients: risk scores integrating host and virus profiles. Hepatology
12. Xie J, Zhang Y, Zhang Q, Han Y, Yin J, Pu R, Shen Q, Lu W, Du 2013;58:546-54.
Y, Zhao J, Han X, Zhang H, Cao G. Interaction of signal transducer 24. Yeh CT, So M, Ng J, Yang HW, Chang ML, Lai MW, Chen TC, Lin
and activator of transcription 3 polymorphisms with hepatitis B virus CY, Yeh T S, Lee WC. Hepatitis B virus-DNA level and basal core
mutations in hepatocellular carcinoma. Hepatology 2013;57:2369-77. promoter A1762T/G1764A mutation in liver tissue independently
13. Yin J, Li N, Han Y, Xue J, Deng Y, Shi J, Guo W, Zhang H, Wang predict postoperative survival in hepatocellular carcinoma.
H, Cheng S, Cao G. Effect of antiviral treatment with nucleotide/ Hepatology 2010;52:1922-33.
nucleoside analogs on postoperative prognosis of hepatitis B virus- 25. Yang HI, Lu SN, Liaw YF, You SL, Sun CA, Wang LY, Hsiao CK,
related hepatocellular carcinoma: a two-stage longitudinal clinical Chen PJ, Chen DS, Chen CJ. Hepatitis B e antigen and the risk of
study. J Clin Oncol 2013;31:3647-55. hepatocellular carcinoma. N Engl J Med 2002;347:168-74.
14. Yin J, Xie J, Liu S, Zhang H, Han L, Lu W, Shen Q, Xu G, Dong H, 26. Norder H, Courouce AM, Coursaget P, Echevarria JM, Lee SD,
Shen J, Zhang J, Han J, Wang L, Liu Y, Wang F, Zhao J, Zhang Q, Mushahwar IK, Robertson BH, Locarnini S, Magnius LO. Genetic
Ni W, Wang H, Cao G. Association between the various mutations in diversity of hepatitis B virus strains derived worldwide: genotypes,
viral core promoter region to different stages of hepatitis B, ranging subgenotypes, and HBsAg subtypes. Intervirology 2004;47:289-309.
of asymptomatic carrier state to hepatocellular carcinoma. Am J 27. Yin J, Zhang H, He Y, Xie J, Liu S, Chang W, Tan X, Gu C, Lu W,
Gastroenterol 2011;106:81-92. Wang H, Bi S, Cui F, Liang X, Schaefer S, Cao G. Distribution and
15. Yin J, Xie J, Zhang H, Shen Q, Han L, Lu W, Han Y, Li C, Ni W, hepatocellular carcinoma-related viral properties of hepatitis B virus
Wang H, Cao G. Significant association of different preS mutations genotypes in Mainland China: a community-based study. Cancer
with hepatitis B-related cirrhosis or hepatocellular carcinoma. J Epidemiol Biomarkers Prev 2010;19:777-86.
Gastroenterol 2010;45:1063-71. 28. Chan HL, Hui AY, Wong ML, Tse AM, Hung LC, Wong VW,
16. Zhang HW, Yin JH, Li YT, Li CZ, Ren H, Gu CY, Wu HY, Liang Sung JJ. Genotype C hepatitis B virus infection is associated with an
XS, Zhang P, Zhao JF, Tan XJ, Lu W, Schaefer S, Cao GW. Risk increased risk of hepatocellular carcinoma. Gut 2004;53:1494-98.
factors for acute hepatitis B and its progression to chronic hepatitis in 29. Yu MW, Yeh SH, Chen PJ, Liaw YF, Lin CL, Liu CJ, Shih WL, Kao
Shanghai, China. Gut 2008;57:1713-20. JH, Chen D S, Chen CJ. Hepatitis B virus genotype and DNA level
17. Zhang Q, Ji XW, Hou XM, Lu FM, DuY, Yin JH, Sun XY, Deng Y, and hepatocellular carcinoma: a prospective study in men. J Natl
Zhao J, Han X, Yang GS, Zhang HW, Chen XM, Shen HB, Wang Cancer Inst 2005;97:265-72.
HY, Cao GW. Effect of functional nuclear factor-kappaB genetic 30. Kao JH, Chen PJ, Lai MY, Chen DS. Hepatitis B genotypes
polymorphisms on hepatitis B virus persistence and their interactions correlate with clinical outcomes in patients with chronic hepatitis B.
with viral mutations on the risk of hepatocellular carcinoma. Ann Gastroenterology 2000;118:554-59.
Oncol 2014;25:2413-9. 31. Yin J, Zhang H, Li C, Gao C, He Y, Zhai Y, Zhang P, Xu L, Tan
18. Zhang Q, Yin J, Zhang Y, Deng Y, Ji X, Du Y, Pu R, Han Y, Zhao X, Chen J, Cheng S, Schaefer S, Cao G. Role of hepatitis B virus
J, Han X, Zhang H, Cao G. HLA-DP polymorphisms affect the genotype mixture, subgenotypes C2 and B2 on hepatocellular
outcomes of chronic hepatitis B virus infections, possibly through carcinoma: compared with chronic hepatitis B and asymptomatic
interacting with viral mutations. J Virol 2013;87:12176-86. carrier state in the same area. Carcinogenesis 2008;29:1685-91.
19. Alexandrov LB, Nik-Zainal S, Wedge DC, Aparicio SA, Behjati S, 32. Deng Y, Du Y, Zhang Q, Han X, Cao G. Human cytidine deaminases
Biankin AV, Bignell GR, Bolli N, Borg A, Borresen-Dale AL, Boyault facilitate hepatitis B virus evolution and link inflammation and
338 Hepatoma Research ¦ Volume 2 ¦ December 23, 2016